Angioscopic findings 1 year after percutaneous coronary intervention for chronic total occlusion

J Cardiol. 2023 Jan;81(1):91-96. doi: 10.1016/j.jjcc.2022.08.008. Epub 2022 Sep 1.

Abstract

Background: Chronic total occlusion (CTO) is a high-risk factor for stent thrombosis, but little is known about the difference in neointimal healing between CTO and non-CTO lesions regarding implanted stents. We investigated factors affecting neointimal healing after stent implantation for CTO and non-CTO lesions using angioscopy.

Methods: We retrospectively evaluated 106 stents in 85 consecutive patients between March 2016 and July 2020. Their average age was 68 ± 11 years, and participants (73 male and 12 female) underwent follow-up angiography and angioscopy 1 year after percutaneous coronary intervention (PCI). The stents (n = 106) were divided into three groups according to the lesion status at the previous PCI: CTO (n = 17), acute coronary syndrome (ACS) (n = 35), and stable coronary artery disease without CTO or non-CTO (n = 54).

Results: The neointimal stent coverage grade was significantly lower in the CTO and ACS groups than in the non-CTO group (0.4 ± 0.5, 0.9 ± 0.8, and 1.4 ± 0.8, respectively, p < 0.001). Thrombi were significantly more frequent in CTO and ACS than in non-CTO (71 %, 51 %, and 15 %, respectively, p < 0.001). The yellow grade in CTO was comparable to that in ACS but significantly higher in CTO than in non-CTO (CTO vs. ACS vs. non-CTO 1.5 ± 0.7, 1.4 ± 0.6, and 0.9 ± 0.7, respectively, p = 0.007).

Conclusions: Delayed healing occurs in stents implanted for CTO lesions. Longer dual-antithrombotic therapy may be beneficial.

Keywords: Acute coronary syndrome; Angioscopy; Chronic total occlusion; Drug-eluting stent; Neointimal coverage.

MeSH terms

  • Aged
  • Angioscopy
  • Chronic Disease
  • Coronary Angiography / adverse effects
  • Coronary Occlusion* / diagnostic imaging
  • Coronary Occlusion* / therapy
  • Coronary Thrombosis* / pathology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neointima
  • Percutaneous Coronary Intervention* / adverse effects
  • Retrospective Studies
  • Treatment Outcome